Free Trial
NASDAQ:STDY

SteadyMed (STDY) Stock Price, News & Analysis

→ A new way to collect income from stocks (From DTI) (Ad)
Free STDY Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$4.73
▼
$4.73
50-Day Range
N/A
52-Week Range
$2.60
▼
$6.45
Volume
160 shs
Average Volume
85,138 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis

About SteadyMed

SteadyMed Ltd., together with its subsidiaries, operates as a specialty pharmaceutical company that focuses on the development and commercialization of drug product candidates for the treatment of orphan and high-value diseases with unmet parenteral delivery needs. The company's product candidates are enabled by its proprietary PatchPump, a discreet, water-resistant, and disposable drug administration technology. Its lead drug product candidate is Trevyent that is used for treating pulmonary arterial hypertension. The company also develops two drug product candidates for the treatment of post-surgical and acute pain in the home setting. It has operations in Israel, the United States, and Europe. SteadyMed Ltd. was founded in 2005 and is headquartered in San Ramon, California.

STDY Stock News Headlines

December 20, 2023 | washingtonpost.com
Apes may remember old friends and family decades later, study says
December 18, 2023 | bbc.com
Social media effect 'tiny' in teenagers, large study finds
April 27, 2024 | True Market Insiders (Ad)
The “Next Bitcoin”? 10 CENT Crypto Set to Explode
The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…
November 14, 2023 | usatoday.com
Should we clean up the trash in our oceans? New study has a controversial answer.
October 24, 2023 | usatoday.com
'Climate captives': Frogs, salamanders and toads dying rapidly as Earth warms, study says
October 3, 2023 | forbes.com
Fluoride And IQ? What Is The Link, What This Study Says
September 3, 2023 | foxnews.com
Babies, young child exposed to more screen time linked with developmental delays: Study
August 28, 2023 | marketwatch.com
Cost of Owning a Dog in Every State (2023 Study)
April 27, 2024 | True Market Insiders (Ad)
The “Next Bitcoin”? 10 CENT Crypto Set to Explode
The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…
August 23, 2023 | foxnews.com
More younger people are receiving cancer diagnoses, study finds — especially this type
July 8, 2023 | usatoday.com
Climate change fueled California's recent surge in catastrophic wildfire seasons, study says
June 19, 2023 | usatoday.com
Study reveals how alcohol has heart benefits. Why you should still sip with caution.
June 10, 2023 | usatoday.com
The sixth extinction is underway, study finds. But here's why all hope is not lost.
June 2, 2023 | forbes.com
Best Bar Exam Study Loans Of June 2023
June 2, 2023 | usatoday.com
Study identifies symptoms that distinguish long COVID ‒ an essential step toward much-needed treatment
May 15, 2023 | forbes.com
Miss USA And Miss America Winners’ Home States May See Increase In Body Image Issues, Study Shows
May 11, 2023 | bbc.co.uk
Go The Distance: Study Skills
May 11, 2023 | marketwatch.com
Wearable Injectors Market Research Provided SOWT Analysis [Latest Report] (2023-2030)
May 9, 2023 | dailymail.co.uk
Face masks may raise risk of stillbirths, testicular issues and cognitive decline, study says
May 7, 2023 | usnews.com
Acad of Entre Stdy@Louverture
March 27, 2023 | marketwatch.com
Wearable Injectors Market Size and Forecast till 2030
March 24, 2023 | marketwatch.com
Wearable Injectors Market Major Players, Anlysis and Forecast till 2031
March 20, 2023 | foxnews.com
'Dad jokes' help kids develop into healthy adults: study
March 17, 2023 | nypost.com
study says
March 17, 2023 | marketwatch.com
Subcutaneous Infusion Systems Market Key Players and Forecast till 2028
March 12, 2023 | marketwatch.com
Global On-body Injectors Market Scenario Highlighting Key Drivers And Latest Trends 2023 – 2030 By VMReports
March 10, 2023 | marketwatch.com
Intravenous-to-Subcutaneous Drugs Market Competitive Strategy, Trend Analysis and Forecast till 2029
See More Headlines
Receive STDY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SteadyMed and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/14/2018
Today
4/27/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:STDY
CUSIP
N/A
CIK
1619087
Web
www.steadymed.com
Phone
925-272-4999
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Cheap Stocks to Buy Now Cover
10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Jonathan M. N. Rigby (Age 50)
    Pres, CEO & Director
  • Mr. David W. Nassif (Age 64)
    Exec. VP & CFO
  • Mr. Robert Zwolinski
    Sr. VP of Operations
  • Ms. Marylyn Rigby
    Sr. Director of Investor Relations and Marketing
  • Mr. Carl Hicks Jr.
    Editor & Chief of Bephenomental.com

Key Competitors

View All Competitors

STDY Stock Analysis - Frequently Asked Questions

How were SteadyMed's earnings last quarter?

SteadyMed Ltd. (NASDAQ:STDY) released its quarterly earnings data on Tuesday, August, 14th. The company reported ($0.38) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by $0.17.

What other stocks do shareholders of SteadyMed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SteadyMed investors own include Amicus Therapeutics (FOLD), Fate Therapeutics (FATE), Madrigal Pharmaceuticals (MDGL), Neurocrine Biosciences (NBIX), Rigel Pharmaceuticals (RIGL), Supernus Pharmaceuticals (SUPN), Verastem (VSTM) and Biocept (BIOC).

When did SteadyMed IPO?

SteadyMed (STDY) raised $56 million in an initial public offering on Friday, March 20th 2015. The company issued 4,300,000 shares at a price of $12.00-$14.00 per share. Wells Fargo Securities and RBC Capital Markets acted as the underwriters for the IPO and JMP Securities was co-manager.

This page (NASDAQ:STDY) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
This AI Trade Machine Made 1,729%* (With 89% Wins)
Prosper Trading Academy
He Is Giving Away Bitcoin
Crypto Swap Profits
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press
Protect Your Bank Account Before It’s Too Late
Weiss Ratings
Jeff Bezos Just Humiliated Elon Musk
InvestorPlace
4 Cryptos BETTER than Bitcoin
True Market Insiders